Reid Bissonnette

Biography

Dr. Bissonnette oversees the pharmacology and translational activities supporting the advancement of HUYA Bioscience International’s lead candidates, as well contributing to the assessment of new therapeutic opportunities in oncology and inflammation. Dr. Bissonnette has more than 20 years of drug discovery experience in therapeutic areas of oncology, inflammation and immunology, and has experience in small molecules, peptides, biologics and drug conjugates. Prior to joining HUYA, Dr. Bissonnette has served as Associate Director/Oncology Therapeutic Area Lead at CovX Research (Pfizer WRD) and at Ligand Pharmaceuticals as Associate Director, Molecular Biology/Oncology, where he was responsible for oncology and inflammation drug discovery, including target ID, validation, lead development and clinical candidate selection, new technology acquisition, as well supporting compounds in clinical development. He was a major contributor in the approvals and post-approval development of Targretin and ONTAK. Dr. Bissonnette completed his B.Sc. in Biochemistry and his PhD in Tumor Immunology at McGill University. He completed his post-doctoral training at the La Jolla Institute for Allergy and Immunology.

Research Interest

pharmaceutical